Sector footprint
$120.1M in exports
Reported chemicals exports in 2024 across 17 qualifying HS6 products.
Sector export playbook ยท HS 28-38
Explore Niger's HS 28-38 product portfolio, buyer markets, growth signals, and diversification opportunities. Use this guide to prioritize research, not to treat calculated indicators as guaranteed sales.
Chemicals capability
Compare exporter scale with product breadth, buyer demand, growth, and destination reach. A large sector does not remove the need for product, compliance, pricing, and buyer validation.
Sector footprint
Reported chemicals exports in 2024 across 17 qualifying HS6 products.
Global demand
The sector's reported buyer import base provides context for product and market prioritization.
How to use the guide
Start with products that combine demand and exporter capability, then validate standards, route economics, buyers, and competition.
Product portfolio
Each HS6 product is ranked by calculated opportunity and shown with reported market size, exporter exports, growth, and destination reach.
| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
|---|---|---|---|---|---|---|
| HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $142.8B | $132.6K | $69.8B | +3.7% | 12 | +0.0% |
| HS 382200Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $16.7B | $85.1K | $6.9B | -7.2% | 7 | +0.0% |
| HS 330499Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $16.3B | $27.7K | $6.9B | +118.5% | 3 | +0.0% |
| HS 284410Uranium: natural uranium and its compounds, alloys, dispersions (including cermets), ceramic products and mixtures containing natural uranium or natural uranium compounds | $4.1B | $39.3M | $5.8B | -16.5% | 2 | +2.0% |
| HS 330300Perfumes and toilet waters | $6.6B | $6.2K | $3.6B | +13.1% | 3 | +0.0% |
| HS 382499Chemical products, mixtures and preparations: n.e.c. heading 3824 | $4.8B | $3.2K | $3.4B | +21.9% | 4 | +0.0% |
| HS 284420Uranium: enriched in U235, plutonium, their compounds, alloys dispersions (including cermets), ceramic products and mixtures containing uranium enriched in U235, plutonium or compounds of these products | $6.8B | $80.4M | $2.3B | +12.3% | 2 | +2.9% |
| HS 300439Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $3.0B | $62.5K | $2.0B | +33.1% | 1 | +0.0% |
| HS 340220Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $3.1B | $31.8K | $1.9B | +16.7% | 2 | +0.0% |
| HS 281820Aluminium oxide: other than artificial corundum | $511.6M | $225.0 | $823.8M | -37.3% | 1 | +0.0% |
| HS 340600Candles, tapers and the like | $1.0B | $28.7K | $640.8M | -14.7% | 1 | +0.0% |
| HS 320910Paints and varnishes: based on acrylic or vinyl polymers, dispersed or dissolved in an aqueous medium | $513.1M | $210.6 | $614.3M | -4.6% | 1 | +0.0% |
| HS 340319Lubricating preparations: (other than for the treatment of textile and similar materials), containing less than 70% (by weight) of petroleum oils or oils obtained from bituminous minerals | $371.3M | $34.6 | $457.6M | -20.2% | 1 | +0.0% |
| HS 280429Gases, rare: other than argon | $584.4M | $232.4 | $453.4M | +33.4% | 1 | +0.0% |
| HS 293359Heterocyclic compounds: containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea (barbituric acid) and its derivatives),and loprazolam, mecloqualone, methaqualone, zipeprol and salts thereof | $397.1M | $37.2K | $433.9M | -1.4% | 1 | +0.0% |
| HS 300290Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $979.8M | $1.3K | $389.2M | +49.8% | 1 | +0.0% |
| HS 300212Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $1.4B | $321.5 | $385.3M | +16.2% | 1 | +0.0% |
Best markets
Markets are ranked by calculated opportunity across the qualifying products in this sector view.
CHE
1 products represented in the sector.
$27.7B$41.0B reported buyer importsCHN
3 products represented in the sector.
$11.1B$26.3B reported buyer importsSVN
1 products represented in the sector.
$9.7B$7.6B reported buyer importsCAN
7 products represented in the sector.
$9.4B$13.6B reported buyer importsUSA
5 products represented in the sector.
$8.4B$22.4B reported buyer importsBEL
2 products represented in the sector.
$7.5B$19.6B reported buyer importsGBR
3 products represented in the sector.
$6.8B$18.2B reported buyer importsFRA
6 products represented in the sector.
$6.3B$18.5B reported buyer importsESP
1 products represented in the sector.
$5.2B$11.9B reported buyer importsIRL
1 products represented in the sector.
$3.2B$6.4B reported buyer importsRUS
1 products represented in the sector.
$2.6B$1.9B reported buyer importsDEU
2 products represented in the sector.
$2.5B$6.2B reported buyer importsGrowth stars
Average product-level CAGR is a screening signal. Confirm the latest trend, base effects, buyer quality, and commercial feasibility before acting.
| Product | Average CAGR | Opportunity | Markets |
|---|---|---|---|
| HS 330499Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | +118.5% | $6.9B | 3 |
| HS 300290Toxins, cultures of micro-organisms (excluding yeasts) and similar products | +49.8% | $389.2M | 1 |
| HS 280429Gases, rare: other than argon | +33.4% | $453.4M | 1 |
| HS 300439Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | +33.1% | $2.0B | 1 |
| HS 382499Chemical products, mixtures and preparations: n.e.c. heading 3824 | +21.9% | $3.4B | 4 |
| HS 340220Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | +16.7% | $1.9B | 2 |
| HS 300212Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | +16.2% | $385.3M | 1 |
| HS 330300Perfumes and toilet waters | +13.1% | $3.6B | 3 |
| HS 284420Uranium: enriched in U235, plutonium, their compounds, alloys dispersions (including cermets), ceramic products and mixtures containing uranium enriched in U235, plutonium or compounds of these products | +12.3% | $2.3B | 2 |
| HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | +3.7% | $69.8B | 12 |
Diversification opportunities
Destination count is a simple breadth indicator. It does not measure destination concentration or guarantee resilience.
HS 300490
HS 382200
HS 382499
HS 330499
HS 330300
HS 284410
HS 284420
HS 340220
Frequently asked questions
Practical guidance for interpreting sector scale, growth, product breadth, and buyer markets.
Compare sector exports, product breadth, buyer markets, growth, and global demand. These signals identify research priorities rather than guarantee market access.
Products with higher average reported growth in the screened rows. Validate the time period, base effects, buyer demand, and current exporter position.
Products reaching more buyer markets in the screened data. Destination breadth is useful context but does not replace concentration, route, or buyer analysis.
Data source
OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). OECD BIMTS is the primary trade series for this view. Supporting bilateral trade context uses CEPII BACI bilateral trade flows (202601) under Etalab 2.0 Open Licence. Yugalinks presents derived views of reported observations and calculated indicators. Data terms: OECD Terms & Conditions.